Rajiv D. Pandya – Trademark Portfolio
Entity Type: 01
Rajiv D. Pandya holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 13 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include PANPLASTY, PANORTHOPAEDICS, PANPLASTY GUIDE, PANPLASTY TECHNIQUE, and THE ART OF PRECISION. The owner is based in Stockbridge, GA.
1035 Southcrest Drive, Suite 100
Stockbridge, GA 30281
Showing of trademarks Trademarks
Trademark Classifications
Rajiv D. Pandya's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Rajiv D. Pandya have?
Rajiv D. Pandya has 18 U.S. trademarks filed with the USPTO. Of these, 5 registered, 12 abandoned, 1 cancelled.
What trademark classes does Rajiv D. Pandya file in?
Rajiv D. Pandya files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 10 (Medical Apparatus), Class 35 (Advertising & Business). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Rajiv D. Pandya's most well-known trademarks?
Rajiv D. Pandya's registered trademark portfolio includes well-known marks such as PANPLASTY, PANORTHOPAEDICS, PANPLASTY GUIDE, PANPLASTY TECHNIQUE, and THE ART OF PRECISION. These are among 5 currently registered trademarks in the portfolio.
What is Rajiv D. Pandya's trademark registration success rate?
Rajiv D. Pandya has a 28% trademark registration rate, with 5 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.